-
The drug, lecanemab, was proven to moderately slow the disease in early stages. It also comes with the potential for some serious side effects, such as brain bleeding and brain inflammation.
-
Two UT Health San Antonio doctors discuss the barriers behind the lack of Latino representation in clinic trials and the massive need to increase Latino participation.